Octreotide studies: 134 papers with results
Page 2 of 3
Octreotide has 2,449 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.
- Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly.
Amato G · Clinical endocrinology · 2002
Randomized controlled trial · 6 results
- Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.
Lustig RH · The Journal of clinical endocrinology and metabolism · 2003
Randomized controlled trial · 6 results
- Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.
Boehm BO · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2001
Randomized controlled trial · 3 results
- Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.
Ripamonti C · Journal of pain and symptom management · 2000
Randomized controlled trial · 4 results
- Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
Ma P · Clinical pharmacology and therapeutics · 2005
Randomized controlled trial · 5 results
- The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
van der Hoek J · Clinical endocrinology · 2005
Randomized controlled trial · 10 results
- Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes.
Serri O · JAMA · 1991
Randomized controlled trial · 3 results
- Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
Geer RJ · Annals of surgery · 1990
Randomized controlled trial · 13 results
- Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide.
Malfertheiner P · Gut · 1995
Randomized controlled trial · 4 results
- A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly.
Andries M · Clinical endocrinology · 2008
Randomized controlled trial · 19 results
- Pharmacokinetics of SMS 201-995 in healthy subjects.
Kutz K · Scandinavian journal of gastroenterology. Supplement · 1986
Randomized controlled trial · 8 results
- The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.
Grant MB · Diabetes care · 2000
Randomized controlled trial · 2 results
- Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.
Mercadante S · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2000
Randomized controlled trial · 2 results
- A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
Lustig RH · International journal of obesity (2005) · 2006
Randomized controlled trial · 17 results
- Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.
Zhou Y · Journal of gastroenterology and hepatology · 2002
Randomized controlled trial · 5 results
- Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
Manolakopoulos S · Gastrointestinal endoscopy · 2002
Randomized controlled trial · 4 results
- Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.
Tiberg F · British journal of clinical pharmacology · 2015
Randomized controlled trial · 9 results
- Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.
Melmed S · The Journal of clinical endocrinology and metabolism · 2015
Non-randomized trial · 7 results
- Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study.
Bronstein MD · BMC endocrine disorders · 2016
Non-randomized trial · 14 results
- Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.
Chrispijn M · Journal of hepatology · 2013
Non-randomized trial · 1 result
- Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
Johnson DR · Neuro-oncology · 2011
Non-randomized trial · 10 results
- Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly.
Chanson P · Clinical endocrinology · 2000
Non-randomized trial · 11 results
- Octreotide as primary therapy for acromegaly.
Newman CB · The Journal of clinical endocrinology and metabolism · 1998
Non-randomized trial · 18 results
- Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M · Cancer · 1996
Non-randomized trial · 5 results
- Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
Arnold R · Gut · 1996
Non-randomized trial · 7 results
- Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.
Arnold R · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2005
Non-randomized trial · 1 result
- Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy.
Dickinson AJ · The Journal of clinical endocrinology and metabolism · 2004
Non-randomized trial · 8 results
- Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Saltz L · Cancer · 1993
Non-randomized trial · 4 results
- Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
Klijn JG · British journal of cancer · 1990
Non-randomized trial · 8 results
- Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.
O'Toole D · Cancer · 2000
Non-randomized trial · 13 results
- Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
Chiodini PG · The Journal of clinical endocrinology and metabolism · 1987
Non-randomized trial · 5 results
- Palliation of malignant intestinal obstruction using octreotide.
Khoo D · European journal of cancer (Oxford, England : 1990) · 1994
Non-randomized trial · 2 results
- Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK · The American journal of gastroenterology · 2005
Non-randomized trial · 6 results
- Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
Butturini G · Endocrine-related cancer · 2006
Non-randomized trial · 9 results
- Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
Ho KY · Annals of internal medicine · 1990
Non-randomized trial · 14 results
- Octreotide abolishes the acute decrease in bone turnover in response to oral glucose.
Clowes JA · The Journal of clinical endocrinology and metabolism · 2003
Non-randomized trial · 3 results
- Sandostatin LAR in acromegalic patients: a dose-range study.
Fløgstad AK · The Journal of clinical endocrinology and metabolism · 1995
Non-randomized trial · 9 results
- Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study.
Pomier-Layrargues G · Hepatology (Baltimore, Md.) · 2003
Non-randomized trial · 9 results
- Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output.
Nubiola-Calonge P · Lancet (London, England) · 1987
Non-randomized trial · 3 results
- A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J · The Journal of clinical endocrinology and metabolism · 2004
Non-randomized trial · 5 results
- The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
Kalambokis G · The American journal of gastroenterology · 2005
Non-randomized trial · 7 results
- Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
Hopman WP · Annals of surgery · 1988
Non-randomized trial · 6 results
- Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients.
Christensen SE · Clinical endocrinology · 1987
Non-randomized trial · 15 results
- A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
Turner HE · Clinical endocrinology · 1999
Non-randomized trial · 5 results
- Local arterial vasoconstriction induced by octreotide in patients with cirrhosis.
Chatila R · Hepatology (Baltimore, Md.) · 2000
Non-randomized trial · 4 results
- Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B · Digestion · 1987
Non-randomized trial · 18 results
- Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.
Jenkins SA · The British journal of surgery · 1985
Non-randomized trial · 10 results
- Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine.
Hoeldtke RD · Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2006
Non-randomized trial · 5 results
- The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
Lamberts SW · The Journal of clinical endocrinology and metabolism · 1985
Non-randomized trial · 5 results
- Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
Boyle PJ · The Journal of clinical endocrinology and metabolism · 1993
Non-randomized trial · 6 results